Activation of AMPK participates hydrogen sulfide-induced cyto-protective effect against dexamethasone in osteoblastic MC3T3-E1 cells

Biochemical and Biophysical Research Communications

Volumn 454, Issue 1, 2014, Pages 42-47

  Yang, Ming ^a   Huang, Yue ^a   Chen, Jia ^a   Chen, Yi Lei ^a   Ma, Jian Jun ^a   Shi, Pei Hua ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

AMPK and oxidative stress; Dexamethasone; Hydrogen sulfide; Osteoporosis

Indexed keywords

ADENYLATE KINASE; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; DEXAMETHASONE; HYDROGEN SULFIDE; LACTATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; ADENOSINE TRIPHOSPHATE; AMPK ALPHA1 SUBUNIT, MOUSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE NECROSIS; CELL DAMAGE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; OXIDATIVE STRESS; 3T3 CELL LINE; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENE SILENCING; GENETICS; METABOLISM; OSTEONECROSIS; PATHOLOGY;

3T3 CELLS; ADENOSINE TRIPHOSPHATE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; CELL SURVIVAL; CYSTATHIONINE BETA-SYNTHASE; CYSTATHIONINE GAMMA-LYASE; CYTOPROTECTION; DEXAMETHASONE; ENZYME ACTIVATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYDROGEN SULFIDE; MICE; OSTEOBLASTS; OSTEONECROSIS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING;

EID: 84910614723     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.10.033     Document Type: Article

References (32)

1. H. Schacke, W.D. Docke, K. Asadullah, Mechanisms involved in the side effects of glucocorticoids, Pharmacol. Ther. 96 (2002) 23-43.
2. D. den Uyl, I.E. Bultink, W.F. Lems, Advances in glucocorticoid-induced osteoporosis, Curr. Rheumatol. Rep. 13 (2011) 233-240.
3. R.S. Weinstein, Clinical practice. Glucocorticoid-induced bone disease, N. Engl. J. Med. 365 (2011) 62-70.
4. M.A. Kerachian, C. Seguin, E.J. Harvey, Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action, J. Steroid Biochem. Mol. Biol. 114 (2009) 121-128.
5. B. Souttou, D. Raulais, M. Vigny, Pleiotrophin induces angiogenesis: involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways, J. Cell. Physiol. 187 (2001) 59-64.
6. H.A. Himburg, G.G. Muramoto, P. Daher, S.K. Meadows, J.L. Russell, P. Doan, J.T. Chi, A.B. Salter, W.E. Lento, T. Reya, N.J. Chao, J.P. Chute, Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells, Nat. Med. 16 (2010) 475-482.
7. D.J. Lefer, A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide, Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 17907-17908.
8. H. Kimura, Signaling molecules: hydrogen sulfide and polysulfide, Antioxid. Redox Signal. (2014).
9. H. Kimura, N. Shibuya, Y. Kimura, Hydrogen sulfide is a signaling molecule and a cytoprotectant, Antioxid. Redox Signal. 17 (2012) 45-57.
10. L.F. Hu, M. Lu, Z.Y. Wu, P.T. Wong, J.S. Bian, Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function, Mol. Pharmacol. 75 (2009) 27-34.
11. Z.S. Xu, X.Y. Wang, D.M. Xiao, L.F. Hu, M. Lu, Z.Y. Wu, J.S. Bian, Hydrogen sulfide protects MC3T3-E1 osteoblastic cells against H2O2-induced oxidative damage-implications for the treatment of osteoporosis, Free Radic. Biol. Med. 50 (2011) 1314-1323.
12. D.G. Hardie, F.A. Ross, S.A. Hawley, AMPK: a nutrient and energy sensor that maintains energy homeostasis, Nat. Rev. Mol. Cell Biol. 13 (2012) 251-262.
13. Z. Luo, A.K. Saha, X. Xiang, N.B. Ruderman, AMPK, the metabolic syndrome and cancer, Trends Pharmacol. Sci. 26 (2005) 69-76.
14. S.M. Jeon, N.S. Chandel, N. Hay, AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress, Nature 485 (2012) 661-665.
15. K. Inoki, T. Zhu, K.L. Guan, TSC2 mediates cellular energy response to control cell growth and survival, Cell 115 (2003) 577-590.
16. Y. Zhu, J. Zhou, R. Ao, B. Yu, A-769662 protects osteoblasts from hydrogen dioxide-induced apoptosis through activating of AMP-activated protein kinase (AMPK), Int. J. Mol. Sci. 15 (2014) 11190-11203.
17. C. She, L.Q. Zhu, Y.F. Zhen, X.D. Wang, Q.R. Dong, Activation of AMPK protects against hydrogen peroxide-induced osteoblast apoptosis through autophagy induction and NADPH maintenance: new implications for osteonecrosis treatment?, Cell Signal. 26 (2014) 1-8.
18. H.J. Lee, M.M. Mariappan, D. Feliers, R.C. Cavaglieri, K. Sataranatarajan, H.E. Abboud, G.G. Choudhury, B.S. Kasinath, Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells, J. Biol. Chem. 287 (2012) 4451-4461.
19. X. Zhou, Y. Cao, G. Ao, L. Hu, H. Liu, J. Wu, X. Wang, M. Jin, S. Zheng, X. Zhen, N.J. Alkayed, J. Jia, J. Cheng, CaMKKbeta-dependent activation of amp-activated protein kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation, Antioxid. Redox Signal. (2014).
20. R.J. Amato, J. Jac, S. Giessinger, S. Saxena, J.P. Willis, A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer, Cancer 115 (2009) 2438-2446.
21. Y. Yang, X.J. Li, Z. Chen, X.X. Zhu, J. Wang, L.B. Zhang, L. Qiang, Y.J. Ma, Z.Y. Li, Q.L. Guo, Q.D. You, Wogonin induced calreticulin/annexin A1 exposure dictates the immunogenicity of cancer cells in a PERK/AKT dependent manner, PLoS One 7 (2012) e50811.
22. R.S. Weinstein, R.L. Jilka, A.M. Parfitt, S.C. Manolagas, Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone, J. Clin. Invest. 102 (1998) 274-282.
23. A. Gohel, M.B. McCarthy, G. Gronowicz, Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro, Endocrinology 140 (1999) 5339-5347.
24. S.I. Yun, H.Y. Yoon, S.Y. Jeong, Y.S. Chung, Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta, J. Bone Miner. Metab. 27 (2009) 140-148.
25. M. Lu, L.F. Hu, G. Hu, J.S. Bian, Hydrogen sulfide protects astrocytes against H(2)O(2)-induced neural injury via enhancing glutamate uptake, Free Radic. Biol. Med. 45 (2008) 1705-1713.
26. L.F. Hu, P.T. Wong, P.K. Moore, J.S. Bian, Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia, J. Neurochem. 100 (2007) 1121-1128.
27. K. Eto, H. Kimura, The production of hydrogen sulfide is regulated by testosterone and S-adenosyl-L-methionine in mouse brain, J. Neurochem. 83 (2002) 80-86.
28. C.L. Kao, L.K. Tai, S.H. Chiou, Y.J. Chen, K.H. Lee, S.J. Chou, Y.L. Chang, C.M. Chang, S.J. Chen, H.H. Ku, H.Y. Li, Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells, Stem Cells Dev. 19 (2010) 247-258.
29. D.A. Hildeman, T. Mitchell, T.K. Teague, P. Henson, B.J. Day, J. Kappler, P.C. Marrack, Reactive oxygen species regulate activation-induced T cell apoptosis, Immunity 10 (1999) 735-744.
30. Y.F. Zhen, G.D. Wang, L.Q. Zhu, S.P. Tan, F.Y. Zhang, X.Z. Zhou, X.D. Wang, P53 dependent mitochondrial permeability transition pore opening is required for dexamethasone-induced death of osteoblasts, J. Cell. Physiol. 229 (2014) 1475-1483.
31. S.C. Manolagas, Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis, Endocr. Rev. 21 (2000) 115-137.
32. C.A. O'Brien, D. Jia, L.I. Plotkin, T. Bellido, C.C. Powers, S.A. Stewart, S.C. Manolagas, R.S. Weinstein, Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength, Endocrinology 145 (2004) 1835-1841.